Orion schedules interim results for October 28. Orion stock stands 13.83 percent above target

Published on 10/20/2026 at 13:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Orion's January-September report is due October 28, 2026, after EUR 1.89 billion in 2025 sales. Orion stock costs EUR 87.65 against a EUR 77.00 target.

Interim results and valuation

Orion will publish its January-September report on October 28, 2026.
Jefferies maintained a Hold rating and a EUR 77.00 target on October 14, 2026.
Orion stock trades at EUR 87.65 at 12:52 p.m. CEST at Lang & Schwarz on October 20, 2026.

Isometrische Grafik der Pharma-Produktionskette, Orion Oyj FI0009014377 — Isometrische 3D-Illustration zeigt Wertschöpfungskette der Pharmaproduktion von Orion Oyj, ISIN FI0009014377, schematisch, Illustration mit AI erstellt.

Orion (FI0009014377) will publish its January-September interim report on October 28, 2026. The date was announced by Nasdaq on October 14, 2026, giving investors a defined next checkpoint for the pharmaceutical company.

October 28 sets the next test

The upcoming report covers the first nine months of 2026 and will be accompanied by a webcast. Orion also lists its latest financial release as the half-year report for January-June 2026.

The recent sequence provides a clear chronology. On October 5, 2026, Orion announced that the first patient had been dosed in the Phase 1/2 ODM-216 trial. On October 6, 2026, Orion announced an agreement with Qilu Pharma Europe covering a pembrolizumab biosimilar for the European market. On October 14, 2026, it set October 28, 2026, for the January-September report.

What does the target imply?

Jefferies maintained a Hold rating and set a EUR 77.00 price target on October 14, 2026, according to Markets Insider. The target is EUR 10.65 below the Lang & Schwarz price, a gap of 13.83 percent based on EUR 87.65.

Revenue sets the historical baseline

Orion reported EUR 1.89 billion in net sales for fiscal year 2025, according to the October 14 release carried by Nasdaq. That figure is historical context rather than a substitute for the forthcoming nine-month update. The October report will show whether the pipeline and commercial portfolio are translating into continued sales growth.

Dates and valuation guide the next move

The next substantiated date is October 28, 2026, the interim-results publication and webcast. The main valuation reference is the EUR 77.00 Jefferies target dated October 14, 2026.

Stock price stays above target

Orion was trading at EUR 87.65 at Lang & Schwarz on October 20, 2026, at 12:52 p.m. CEST. The price was EUR 10.65, or 13.83 percent, above the EUR 77.00 Jefferies target cited by Markets Insider.

The further course of trading is shown by the continuously updated real-time quote of Orion stock.